TRAINING and EDUCATION
Patient Education
UNDERSTANDING
MANTLE CELL LYMPHOMA
Lymphoma is the most common blood cancer. The two main forms of lymphoma are
Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Mantle cell lymphoma (MCL)
is a rare B-cell NHL, comprising about 6 percent of all NHL cases in the United States. Read
below for more about the diagnosis, treatment, and prognosis of MCL.
This “Patient Education” tear sheet was produced in collaboration with the Lymphoma
Research Foundation (LRF) (www.lymphoma.org).
What is Mantle Cell Lymphoma?
Lymphoma occurs when cells of the immune system
called lymphocytes, a type of white blood cell, grow and
multiply uncontrollably. The body has two main types of
lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T lymphocytes (T cells). MCL is a
rare B-cell NHL. The disease is called “mantle cell lymphoma” because the tumor cells originally come from the
“mantle zone” of the lymph node.
How is Mantle Cell Lymphoma Diagnosed?
MCL is usually diagnosed as a late-stage disease that has
spread to the v7G&